Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Biocon> ?p ?o }
Showing triples 1 to 74 of
74
with 100 triples per page.
- Biocon abstract "Biocon Limited (BSE: 532523) is an Indian biopharmaceutical company based in Bangalore Within biopharmaceuticals, the Company manufactures generic active pharmaceutical ingredients (APIs) that are sold in the developed markets of the United States and Europe. It also manufactures biosimilar Insulins, which are sold in India as branded formulations and in both bulk and formulation forms. In research services, Syngene International Limited (Syngene) is engaged in the business of custom research in drug discovery while the other fully owned subsidiary Clinigene International Limited (Clinigene) is in the clinical development space. In December 2009, Biocon acquired the Active Pharma Ingredients (API) undertaking from IDL Speciality Chemicals Ltd., a subsidiary of Gulf Oil Corporation Limited.Located with R & D in Bangalore and API unit in Hyderabad, India, Biocon has two subsidiaries— Syngene, a custom research organisation, and Clinigene, a clinical research organisation. Biocon’s presence straddles four main therapeutic areas—Diabetology, Cardiology, Nephrology and Oncology— and plans to introduce two new divisions, Comprehensive Care, and Immunotherapy, this year.Biocon’s cardiology, nephrology, diabetology and oncology products including BESTOR, BASALOGTM, BioMAb EGFR, STATIX, NUFIL safe, INSUGEN, TACROGRAF, ERYPRO safe, and MYOKINASE are claimed to be considerably less expensive than other leading brands. Two of its novel programs on the verge of proof-of-concept stage are IN-105, which is the only oral insulin in the world to be in long duration clinical trials, and the T1h, a novel humanised monoclonal antibody (MAb), the only first-in-class novel MAb being tested in India for rheumatoid arthritis and psoriasis.Between 2005 and 2010, Biocon entered into more than 2,200 high-value R&D licensing and other deals within the pharmaceuticals and bio-pharmaceutical space. It has also expanded its global footprint to emerging and developed markets through acquisitions, partnerships and in-licensing. Biocon’s Corporate Social Responsibility wing, the Biocon Foundation, is involved in numerous health and education outreach programs targeting the underprivileged sections of India.In 2009–10, Biocon’s net income increased 44% to 24,048 million, crossing the half-billion-dollar mark and profits grew 215% to 2,933 million. The pharmaceutical business exceeded 200,871 million in revenue and the net R&D expenditure increased to 917 million, growing 42% over 2008 and up 282% over 2005, while its research services business crossed 2,807 million.Biocon, Syngene and Clinigene together employ approximately 4,500 personnel including biologists, chemists, medical practitioners, pharmacologists, engineers, finance/legal/marketing analysts, HR generalists and general administrators. Around 6% of its employees have PhD degrees, 45% have a master’s degree, and 33% are graduates. Biocon also collaborates with educational institutes to make courses more industry oriented.".
- Biocon foundedBy Kiran_Mazumdar-Shaw.
- Biocon foundingYear "1978".
- Biocon industry Biotechnology.
- Biocon keyPerson Chief_executive_officer.
- Biocon keyPerson Kiran_Mazumdar-Shaw.
- Biocon locationCity Bangalore.
- Biocon locationCountry India.
- Biocon numberOfEmployees "5585".
- Biocon product Enzyme.
- Biocon product Pharmacology.
- Biocon thumbnail Kiran_Mazumdar_Shaw_1000657_detail.jpg?width=300.
- Biocon wikiPageExternalLink www.biocon.com.
- Biocon wikiPageID "1899802".
- Biocon wikiPageRevisionID "602016814".
- Biocon foundation "1978".
- Biocon founder Kiran_Mazumdar-Shaw.
- Biocon hasPhotoCollection Biocon.
- Biocon homepage www.biocon.com.
- Biocon industry Biotechnology.
- Biocon keyPeople "Kiran Mazumdar-Shaw,".
- Biocon locationCity "Bangalore, Karnataka".
- Biocon locationCountry India.
- Biocon logo "200".
- Biocon name "Biocon Limited".
- Biocon numEmployees "5585".
- Biocon products "Enzymes".
- Biocon products "Pharmaceuticals".
- Biocon subsid "Clinigene".
- Biocon subsid "Syngene".
- Biocon type "Public company".
- Biocon wordnet_type synset-company-noun-1.
- Biocon subject Category:Biotechnology_companies_of_India.
- Biocon subject Category:Companies_based_in_Bangalore.
- Biocon subject Category:Companies_listed_on_the_Bombay_Stock_Exchange.
- Biocon subject Category:Pharmaceutical_companies_established_in_1978.
- Biocon subject Category:Pharmaceutical_companies_of_India.
- Biocon type Abstraction100002137.
- Biocon type BiotechnologyCompaniesOfIndia.
- Biocon type CompaniesBasedInBangalore.
- Biocon type CompaniesEstablishedIn1978.
- Biocon type CompaniesListedOnTheBombayStockExchange.
- Biocon type Company108058098.
- Biocon type DrugCompany108002578.
- Biocon type Group100031264.
- Biocon type Institution108053576.
- Biocon type Organization108008335.
- Biocon type PharmaceuticalCompaniesOfIndia.
- Biocon type SocialGroup107950920.
- Biocon type YagoLegalActor.
- Biocon type YagoLegalActorGeo.
- Biocon type YagoPermanentlyLocatedEntity.
- Biocon type Agent.
- Biocon type Company.
- Biocon type Organisation.
- Biocon type Organization.
- Biocon type Agent.
- Biocon type SocialPerson.
- Biocon type Thing.
- Biocon comment "Biocon Limited (BSE: 532523) is an Indian biopharmaceutical company based in Bangalore Within biopharmaceuticals, the Company manufactures generic active pharmaceutical ingredients (APIs) that are sold in the developed markets of the United States and Europe. It also manufactures biosimilar Insulins, which are sold in India as branded formulations and in both bulk and formulation forms.".
- Biocon label "Biocon".
- Biocon label "Biocon".
- Biocon label "Biocon".
- Biocon sameAs Biocon.
- Biocon sameAs Biocon.
- Biocon sameAs m.064srb.
- Biocon sameAs Q487694.
- Biocon sameAs Q487694.
- Biocon sameAs Biocon.
- Biocon wasDerivedFrom Biocon?oldid=602016814.
- Biocon depiction Kiran_Mazumdar_Shaw_1000657_detail.jpg.
- Biocon homepage www.biocon.com.
- Biocon isPrimaryTopicOf Biocon.
- Biocon name "Biocon Limited".